After two massive quarters of fundraising in 2021, Q3 saw synthetic biology startups hit a huge new all-time high of $6.1 billion – 33% higher than the previous record. The total amount of funding going to synthetic biology startups in total so far this year hit $15 billion.  Most of the growth is attributable to deal count hitting a record 73 transactions, while average deal size was down but still very respectable at $83.6 million. As we alluded to in Q2's report, 2021 will not only be the best investment year ever for synthetic biology, but might bring in as much funding as all of the years from when we started counting in 2009 to 2020 combined ($21.5 billion).Click here to download the report.